Menu
Search
|

Menu

Close
X

Avadel Pharmaceuticals PLC AVDL.OQ (NASDAQ Stock Exchange Global Market)

3.46 USD
-0.04 (-1.14%)
As of 3:24 PM GMT
chart
Previous Close 3.50
Open 3.50
Volume 3,266
3m Avg Volume 47,626
Today’s High 3.50
Today’s Low 3.44
52 Week High 11.91
52 Week Low 2.80
Shares Outstanding (mil) 40.08
Market Capitalization (mil) 444.93
Forward P/E 12.12
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.50 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
82
FY17
173
FY16
150
FY15
173
EPS (USD)
FY18
-0.838
FY17
1.512
FY16
-1.001
FY15
0.600
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
12.12
33.64
Price to Sales (TTM)
vs sector
2.56
5.95
Price to Book (MRQ)
vs sector
5.80
4.89
Price to Cash Flow (TTM)
vs sector
9.27
22.90
Total Debt to Equity (MRQ)
vs sector
114.34
17.74
LT Debt to Equity (MRQ)
vs sector
113.96
13.15
Return on Investment (TTM)
vs sector
21.87
14.22
Return on Equity (TTM)
vs sector
61.57
15.99

EXECUTIVE LEADERSHIP

Craig Stapleton
Non-Executive Independent Chairman of the Board, Since 2014
Salary: --
Bonus: --
Michael Anderson
Chief Executive Officer, Director, Since 2012
Salary: $565,500.00
Bonus: --
Michael Kanan
Senior Vice President, Chief Financial Officer, Since 2015
Salary: $325,000.00
Bonus: --
Gregory Divis
Chief Operating Officer, Chief Commercial Officer, Executive Vice President, Since 2018
Salary: --
Bonus: --
Phillandas Thompson
Senior Vice President, General Counsel, Corporate Secretary, Since 2013
Salary: $297,052.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

Blanchardstown Corporate Park, B
DUBLIN     15

Phone: +3531.4851200

Avadel Pharmaceuticals, PLC is a specialty pharmaceutical company. The Company offers various drug delivery platforms, including Micropump, LiquiTime, Trigger Lock and Medusa. The Company offers its products in various categories, including hospital, including Bloxiverz, Vazculep and Akovaz, and pediatrics, including Karbinal ER, Cefaclor for Oral Suspension, AcipHex Sprinkle and Flexichamber. Bloxiverz is a drug used intravenously in the operating room for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Vazculep is used to treat clinically hypotension resulting primarily from vasodilation in the setting of anesthesia. Akovaz is indicated to treat clinically hypotension in the setting of anesthesia. Cefaclor is indicated for the treatment of otitis media, lower respiratory infections, pharyngitis and tonsillitis, urinary tract infections, and skin and skin structure infections, caused by susceptible organisms.

SPONSORED STORIES